- Home
- ASND vs FHN Comparison
ASND vs FHN Comparison
Compare ASND & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- FHN
- Stock Information
- Founded
- ASND 2006
- FHN 1864
- Country
- ASND Denmark
- FHN United States
- Employees
- ASND N/A
- FHN N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- FHN Major Banks
- Sector
- ASND Health Care
- FHN Finance
- Exchange
- ASND Nasdaq
- FHN Nasdaq
- Market Cap
- ASND 12.0B
- FHN 11.0B
- IPO Year
- ASND 2015
- FHN N/A
- Fundamental
- Price
- ASND $204.05
- FHN $22.57
- Analyst Decision
- ASND Strong Buy
- FHN Buy
- Analyst Count
- ASND 16
- FHN 19
- Target Price
- ASND $240.75
- FHN $24.05
- AVG Volume (30 Days)
- ASND 401.5K
- FHN 11.2M
- Earning Date
- ASND 11-13-2025
- FHN 10-15-2025
- Dividend Yield
- ASND N/A
- FHN 2.66%
- EPS Growth
- ASND N/A
- FHN 28.04
- EPS
- ASND N/A
- FHN 1.55
- Revenue
- ASND $576,332,355.00
- FHN $3,083,000,000.00
- Revenue This Year
- ASND $102.31
- FHN $10.95
- Revenue Next Year
- ASND $76.44
- FHN $3.68
- P/E Ratio
- ASND N/A
- FHN $14.58
- Revenue Growth
- ASND 54.50
- FHN 4.62
- 52 Week Low
- ASND $118.03
- FHN $14.94
- 52 Week High
- ASND $208.16
- FHN $23.26
- Technical
- Relative Strength Index (RSI)
- ASND 60.82
- FHN 50.62
- Support Level
- ASND $187.25
- FHN $22.15
- Resistance Level
- ASND $205.48
- FHN $22.95
- Average True Range (ATR)
- ASND 5.42
- FHN 0.44
- MACD
- ASND 0.41
- FHN -0.06
- Stochastic Oscillator
- ASND 92.16
- FHN 47.35
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.